First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...

Grappling with obesity and the metabolic diseases cascading from it, they are now among the plurality of Americans who have ...

In the 28-day DIO study, mice treated with the HT-6184 and semaglutide combination experienced a notable increase in weight loss. Combining HT-6184 with a subtherapeutic dose of semaglutide (1 nmol/kg ...

Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...

Compounded semaglutide has emerged as a significant development in the management of obesity and type 2 diabetes. As a ...

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

MADRID — The benefits of semaglutide treatment in reducing kidney disease, cardiovascular, and mortality risks in people with ...

Some plans include clinical options like prescription drugs. Over the years, options like Semaglutide and Tirzepatide have ...

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with ...